Page 90 of 248
CRISPR-engineered T cells in patients with refractory cancer
Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE, Xu J, Jung IY, Melenhorst JJ, Plesa G, Shea J, Matlawski T, Cervini A, Gaymon AL, …
February 29, 2020
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
Doman JL, Raguram A, Newby GA, Liu DR. Nat Biotechnol. 2020 Feb 10. PubMed
Confluence of theory and experiment reveals the catalytic mechanism of the Varkud satellite ribozyme
Ganguly A, Weissman BP, Giese TJ, Li NS, Hoshika S, Rao S, Benner SA, Piccirilli JA, York DM. Nat Chem. 2020 Feb;12(2):193-201. PubMed
High-throughput identification of synthetic riboswitches by barcode-free amplicon-sequencing in human cells
Strobel B, Spöring M, Klein H, Blazevic D, Rust W, Sayols S, Hartig JS, Kreuz S. Nat Commun. 2020 Feb 5;11(1):714. PubMed
Impact of Phosphorothioate Chirality on Double-Stranded siRNAs: A Systematic Evaluation of Stereopure siRNA Designs
Sakamuri S, Eltepu L, Liu D, Lam S, Meade BR, Liu B, Dello Iacono G, Kabakibi A, Luukkonen L, Leedom T, Foster M, Bradshaw CW. Chembiochem. 2019 Dec 21. PubMed
Page 90 of 248
